ChinaPharmaMarketingConference.PDFVIP

Registration Hotline: +86 (21) 5292 8862 Plus! Post Conference Site Tour on 13th Sept, 2008 – Limited places! Jointown Group – one of China’s biggest distributors provides you with a unique and practical behind the scenes look into pharma distribution and supply chain operations in China What’s Big in 2008? 1. The China pharma market has emerged as one of the top markets for global drug sales. It is predicted that China will become the world’s largest pharmaceutical market by 2020, with sales topping $60 billion by 2010. 2. Pharmaceutical companies are grappling with the complexity of getting their drugs to the market, seeking effective collaboration with distributors and partners. 3. In the meantime, China healthcare reform in 2008 has significant impact on the pharma industry, creating new channels for distribution via CHCs. This conference will provide a practical overview of China pharma and medical devices markets, equipping you with the know-how to operate more effectively and to exploit growth opportunities. Gather critical insights on: ?? The impact on the pharma industry from the 2008 healthcare reforms ?? “New!” Pharma marketing channels – CHCs ?? SFDA regulatory updates ?? “Fast-growing” pharma marketing channels direct to consumers – third terminal chain stores ?? Insider tips on successful collaboration with distributors! – for both drugs medical devices Key industry and expert speaker panel including: Eric von Zwisler, Chief Executive, Zuellig Pharma China James Lee, General Manager, Logistic Division Zuellig Pharma China David Tao, President Assistant, Fosun Pharma Philip Xiao, President, Profex China Robert W. Pollard, Director of Market Research, Synovate China Amar Urhekar, Managing Director McCann Healthcare Worldwide China Byron Wang, General Manager, Med Pharma China Wang Wei, Chief Appraiser, GYY Judicial Expertise Institution former President of Intelligence Department, SFDA Shanghai Tao Jian Hong, Deputy Director, SFDA